Skip to Content

Additional Content In This Section

TrialNet

TrialNet

Objective

Status

Enrolling

Condition

Type 1 Diabetes

Description

The Natural History Study will screen relatives of people with Type 1 Diabetes to identify those at risk for developing the disease.

Purpose

TrialNet is an international network dedicated to the study, prevention, and early treatment of Type 1 Diabetes. 

Key Inclusion Criteria

  • Individuals 1 to 45 years old who have an immediate family member with Type 1 Diabetes (child, parent. or sibling)
  • Individuals 1 to 20 years old who have an extended family member with Type 1 Diabetes (cousin, niece, nephew, aunt, uncle, grandparent, or half-sibling)
  • Person must not have diabetes
  • Person must not have a previous history of being treated with insulin or oral diabetes medications
  • Person must not be using systemic immunosuppressive agents (topical and inhaled agents are acceptable)
Person must not have any know serious diseases

Key Exclusion Criteria

  • Person must not have diabetes
  • Person must not have a previous history of being treated with insulin or oral diabetes medications
  • Person must not be using systemic immunosuppressive agents (topical and inhaled agents are acceptable)
  • Person must not have any know serious diseases

ClinicalTrials.gov Identifier

NCT00097292

IRB Protocol Number
NATHX1
Principal Investigator(s)
Lori Sondrol, MD

Clinical Trial Categories

  • Pediatrics
Sponsor(s)
National Institute of Diabetes and Digestive and Kidney Diseases
Contact
Renee Hendrickson, RN CCRC at 701-780-1694
or rhendrickson@altru.org